Biocon Limited has named Shreehas Tambe as CEO and Managing Director, effective April 1, 2026.
A long-time Biocon Group executive, Tambe has played a key role in building biologics capabilities, including at Biocon Biologics.
He takes charge as Biocon sharpens its global play in biosimilars and specialty products, with a focus on execution and scale in regulated markets.
Visited 6 times, 1 visit(s) today
